Thomas E. Hanlon Program Director/Senior Research Scientist Degree: Ph.D., Guidance and Counseling, Catholic University of America Phone: 410-837-3977 ext. 225 Fax: 410-752-4218 Email: thanlon@frisrc.org

Research Interests

Dr. Hanlon has had an extensive career in behavioral assessment and treatment evaluation, beginning in 1956 as a member of a psychiatric treatment team investigating the psychopharmacologic treatment of inpatients and outpatients manifesting symptoms of schizophrenia, and from 1974 onward by involvement in a long-term program of investigation of the characteristics and treatment responses of substance-abusers, principally opioid dependent individuals.  Treatment approaches Dr. Hanlon has evaluated in this program include the use of opioid antagonists; methadone maintenance; a self-help group approach to aftercare/relapse prevention, social support services for parolees in conjunction with drug use urinalysis-based surveillance; and the provision of assessment-guided drug abuse treatment designed to bridge the gap between prison and parole drug abuse intervention efforts.

Originally a senior investigator at the Social Research Center of Friends Research Institute, Dr. Hanlon is now the Center’s Research Director.  As such, he participates in overall research project planning, development, and implementation at the Center.  In addition, he has been a Principal Investigator in a continuing drug abuse prevention program that evolved as a result of the Center’s program of research on the etiology of opioid drug dependence.  This drug abuse prevention program has focused on the determination of the characteristics and treatment responsiveness of the adolescent children of methadone maintenance patients and incarcerated drug-dependent (heroin and/or cocaine) mothers.  Presently, as Research Director, he is a member of the SRC’s Executive Committee.  He is also the Principal Investigator for a drug abuse early intervention project targeting high-risk alternative learning students in the Baltimore school system.combined, Dr. Hanlon’s diverse research activities represent a broad interest and involvement in the behavioral sciences that has resulted in an extensive publication record.

Selected Publications

Hanlon, T. E., Carswell, S. B., & Rose, M. (2007). Research on the caretaking of children of incarcerated parents: Findings and their service delivery implications. Children and Youth Services Review, 29,348-362.

Hanlon, T. E., Blatchley, R. J., Bennett-Sears, T., O’Grady, K. E., Rose, M., & Callaman, J. (2005). Vulnerability of children of incarcerated addict mothers: Implications for preventive intervention. Children and Youth Services Review, 27, 67-84.

Hanlon, T. E., O’Grady, K. E., Bennett-Sears, T., & Callaman, J. (2004). Incarcerated drug-abusing mothers: Their characteristics and vulnerability. American Journal of Drug and Alcohol Abuse., 30, 915-934.

Hanlon, T. E., Bateman, R. W., O’Grady, K. E., Simon, B. D., & Carswell, S. B. (2004). Antecedents and correlates of deviant activity in urban youth manifesting behavioral problems. Journal of Primary Prevention, 24, 285-310.

Hanlon, T. E., Bateman, R. W., Simon, B. D., O’Grady, K. E., and Carswell, S. B. (2002). An early community-based intervention for the prevention of substance abuse and other delinquent behavior. Journal of Youth and Adolescence, 31, 459-471.

Kinlock, T. W., and Hanlon, T. E. (2002). Probation and parole interventions. In: C. G. Leukfield, F. Tuns, & D. Farabee (eds. ), Treatment of Drug Offenders: Policies and Issues, Springer Publishing Company.

Hanlon, T. E., O’Grady, K. E., and Bateman, R. W. (2000). Using the Addiction Severity Index to predict treatment outcome among substance abusing parolees. Journal of Offender Rehabilitation, 31 (3/4), 67-79.

Blatchley, R. J., Hanlon, T. E., Nurco, D. N. and O’Grady, K. (2000). Childhood sexual abuse among female addicts and changes in parenting across two generations. In: Fishbein, Diana H. (ed. ), The Science Treatment and Prevention of Antisocial Behaviors. Civic Research Institute, Inc., Publisher, Kingston, New Jersey.

Hanlon, T. E., Nurco, D. N., Bateman, R. W., & O’Grady, K. E. (1999). The relative effects of three approaches to parole supervision of narcotic addicts and cocaine abusers. The Prison Journal, 79 (2), 163-181.

Hanlon, T. E., Nurco, D. N., Bateman, R. W., and O’Grady, K. E. (1998). The response of drug abuser parolees to a combination of treatment and intensive supervision. The Prison Journal, 78 (1), 31-44.

Nurco, D. N., Hanlon, T. E., O’Grady, K. E., and Kinlock, T. W. (1997). The early emergence of narcotic addict types. The American Journal of Drug and Alcohol Abuse, 23 (4), 525-544.

Nurco, D. N., Hanlon, T. E., Bateman, R. W., and Kinlock, T. W. (1995). Drug abuse in the context of correctional surveillance. Journal of Substance Abuse Treatment, 12 (1), 19-27.

Nurco, David N., Hanlon, Thomas E., and Kinlock, Timothy W. (1991). Recent research on the relationship between illicit drug use and crime. Behavioral Sciences and the Law, 9, 221-242.

Hanlon, T. E., Nurco, D. N., Kinlock, T. W., and Duszynski, K. R. (1990). Trends in criminal activity and drug use over an addiction career. American Journal of Drug and Alcohol Abuse, 16 (3&4), 223-238.

Hanlon, T. E. Carpenter, W. T. (1978). Phenomenology of disordered behavior. In: The Psychiatric foundations of Medicine, Volume III: Basic Psychopathology, Balis, G. V., Wurmser, L., McDaniel, E. and Grenell, R. G. (Eds. ), Butterworth Publishers, Inc., Boston, Massachusetts.

Hanlon, T. E., and McCabe, O. L. (1978). Narcotic antagonists and the parolee--Outcome, issues, and new directions.comprehensive Psychiatry, 19, 47-56.

Hanlon, T. E., McCabe, O. L., Savage, C., and Kurland, A. A. (1977). Narcotic antagonist treatment of addict parolees--The failure of an effective approach.comprehensive Psychiatry, 18, 211-219.

Hanlon, T. E., McCabe, O. L., Savage, C., and Kurland, A. A. (1975) A controlled comparison of cyclazocine vs. naloxone treatment of the paroled narcotic addict. International Pharmacopsychiatry, 10, 240-250. (Also published in the Proceedings of the Second Annual National Drug Abuse Conference, Marcel Dekker, Incorporated, New York, New York, 1976).

Hanlon, T. E., Ota K. Y., and Kurland, A. A. (1970).comparative effects of fluphenazine; fluphenazine-chlordiazepoxide and fluphenazine-imipramine. Diseases of the Nervous System, 31, 171-176.

Hanlon, T. E., (1969). Aspects of design and analysis in psychotropic drug studies. In: Drugs and the Brain, Black, P., (Ed. ), The Johns Hopkins Press, Baltimore, Maryland.

Hanlon, T. E., Michaux, M. H., Ota, K. Y., Schaffer, J. W. and Kurland, A. A. (1965). The comparative effectiveness of eight phenothiazines. Psychopharmacologia, 7, 89-106.

Hanlon, T. E., Nussbaum, K., Wittig, B.A., and Kirkland, A. A. (1963). The comparative effectiveness of amitriptyline, perphenazine, and their combination in the treatment of chronic psychiatric female patients. Journal of New Drugs, 4, No. 1, 171-184.

Hanlon, T. E., Kurland, A. A., Esquibel, A. J., and Ota K. Y. (1958). A comparative study of chlorpromazine and triflupromazine in the management of the chronic hospitalized psychotic patient. Journal of Nervous and Mental Disease, 127, No. 1, 17-20.